Biofilms, antimicrobial resistance, and airway infection

New England Journal of Medicine

Volumn 347, Issue 14, 2002, Pages 1110-1111

  Prince, Alice S ^a  

^a Columbia Univ Coll Phys/Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; TETRACYCLINE DERIVATIVE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BIOFILM; CYSTIC FIBROSIS; DRUG EFFICACY; HOST RESISTANCE; HUMAN; INFECTION SENSITIVITY; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RESPIRATORY TRACT INFECTION;

ANTI-BACTERIAL AGENTS; BIOFILMS; CYSTIC FIBROSIS; DRUG RESISTANCE, BACTERIAL; GENE EXPRESSION; HUMANS; PSEUDOMONAS AERUGINOSA;

EID: 0037015541     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMcibr021776     Document Type: Article

References (2)

1. Singh PK, Parsek MR, Greenberg EP, Welsh MJ. A component of innate immunity prevents bacterial biofilm development. Nature 2002;417: 552-5.
2. Drenkard E, Ausubel FM. Pseudomonas biofilm formation and antibiotic resistance are linked to phenotypic variation. Nature 2002;416:740-3.